{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:15:27Z","timestamp":1795216527797,"version":"4.10.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"7845","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2021,2,11]]},"DOI":"10.1038\/s41586-020-3035-9","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T06:05:07Z","timestamp":1606802707000},"page":"320-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":173,"title":["A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate"],"prefix":"10.1038","volume":"590","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-0931","authenticated-orcid":false,"given":"Lorena","family":"Sanchez-Felipe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-777X","authenticated-orcid":false,"given":"Thomas","family":"Vercruysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3493-252X","authenticated-orcid":false,"given":"Sapna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-2632","authenticated-orcid":false,"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2507-9029","authenticated-orcid":false,"given":"Viktor","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-3753","authenticated-orcid":false,"given":"Dominique","family":"Van Looveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-6600","authenticated-orcid":false,"given":"Mahadesh Prasad","family":"Arkalagud Javarappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"Boudewijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3527-1145","authenticated-orcid":false,"given":"Bert","family":"Malengier-Devlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5616-8548","authenticated-orcid":false,"given":"Laurens","family":"Liesenborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7935-0219","authenticated-orcid":false,"given":"Suzanne J. F.","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien","family":"De Keyzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Bervoets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3969-1019","authenticated-orcid":false,"given":"Sarah","family":"Debaveye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-0800","authenticated-orcid":false,"given":"Madina","family":"Rasulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9562-2923","authenticated-orcid":false,"given":"Laura","family":"Seldeslachts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-4745","authenticated-orcid":false,"given":"Li-Hsin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9344-131X","authenticated-orcid":false,"given":"Sander","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-0633","authenticated-orcid":false,"given":"Michael Bright","family":"Yakass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-0798","authenticated-orcid":false,"given":"Babs E.","family":"Verstrepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5330-2617","authenticated-orcid":false,"given":"Kinga P.","family":"B\u00f6sz\u00f6rm\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendoline","family":"Kiemenyi-Kayere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3300-8204","authenticated-orcid":false,"given":"Nikki","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0621-876X","authenticated-orcid":false,"given":"Osbourne","family":"Quaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8520-1060","authenticated-orcid":false,"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-6376","authenticated-orcid":false,"given":"Sebastiaan","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-1056","authenticated-orcid":false,"given":"Ward","family":"Deboutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-9733","authenticated-orcid":false,"given":"Jelle","family":"Matthijnssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-4534","authenticated-orcid":false,"given":"Lotte","family":"Coelmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7554","authenticated-orcid":false,"given":"Corinne","family":"Vandermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-7225","authenticated-orcid":false,"given":"Elisabeth","family":"Heylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-3212","authenticated-orcid":false,"given":"Valentijn","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2441-4729","authenticated-orcid":false,"given":"Zhongde","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4563-8513","authenticated-orcid":false,"given":"Willy","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-9049","authenticated-orcid":false,"given":"Thijs","family":"Kuiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0912-2074","authenticated-orcid":false,"given":"Ernst","family":"Verschoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5975-0354","authenticated-orcid":false,"given":"Christopher","family":"Cawthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-7245","authenticated-orcid":false,"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-2294","authenticated-orcid":false,"given":"Ghislain","family":"Opdenakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5633-3993","authenticated-orcid":false,"given":"Greetje","family":"Vande Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4246-6303","authenticated-orcid":false,"given":"Birgit","family":"Weynand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E.","family":"Teuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9685-6836","authenticated-orcid":false,"given":"Patrick","family":"Matthys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-7514","authenticated-orcid":false,"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5785-8276","authenticated-orcid":false,"given":"Hendrik","family":"Jan Thibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-9166","authenticated-orcid":false,"given":"Kai","family":"Dallmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"3035_CR1","unstructured":"WHO. Draft landscape of COVID-19 candidate vaccines, https:\/\/www.who.int\/who-documents-detail\/draft-landscape-of-covid-19-candidate-vaccines (accessed 4 November 2020)."},{"key":"3035_CR2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19684-y","volume":"11","author":"R Boudewijns","year":"2020","unstructured":"Boudewijns, R. et al. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat. Commun. 11, 5838 (2020).","journal-title":"Nat. Commun."},{"key":"3035_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell 182, 73\u201384.e16 (2020).","journal-title":"Cell"},{"key":"3035_CR4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","volume":"21","author":"AD Barrett","year":"2009","unstructured":"Barrett, A. D. & Teuwen, D. E. Yellow fever vaccine \u2013 how does it work and why do rare cases of serious adverse events take place? Curr. Opin. Immunol. 21, 308\u2013313 (2009).","journal-title":"Curr. Opin. Immunol."},{"key":"3035_CR5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","volume":"8","author":"SJ Draper","year":"2010","unstructured":"Draper, S. J. & Heeney, J. L. Viruses as vaccine vectors for infectious diseases and cancer. Nat. Rev. Microbiol. 8, 62\u201373 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"3035_CR6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/hv.28117","volume":"10","author":"MC Bonaldo","year":"2014","unstructured":"Bonaldo, M. C., Sequeira, P. C. & Galler, R. The yellow fever 17D virus as a platform for new live attenuated vaccines. Hum. Vaccin. Immunother. 10, 1256\u20131265 (2014).","journal-title":"Hum. Vaccin. Immunother."},{"key":"3035_CR7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/17474086.2017.1259559","volume":"9","author":"O Afonja","year":"2016","unstructured":"Afonja, O. et al. Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience. Expert Rev. Hematol. 9, 1151\u20131164 (2016).","journal-title":"Expert Rev. Hematol."},{"key":"3035_CR8","unstructured":"ICH. Quality guidelines for pharmaceutical quality based on Good Manufacturing Practice (GMP); Quality of Biotechnological Products (Q5A\u2013Q5E), https:\/\/www.ich.org\/page\/quality-guidelines (accessed 4 November 2020)."},{"key":"3035_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e6 (2020).","journal-title":"Cell"},{"key":"3035_CR10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du, L. et al. The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7, 226\u2013236 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"3035_CR11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"3035_CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","volume":"586","author":"NB Mercado","year":"2020","unstructured":"Mercado, N. B. et al. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature 586, 583\u2013588 (2020).","journal-title":"Nature"},{"key":"3035_CR13","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1016\/j.vaccine.2010.10.070","volume":"28","author":"M Ferguson","year":"2010","unstructured":"Ferguson, M., Shin, J., Knezevic, I., Minor, P. & Barrett, A. WHO Working Group on technical specifications for manufacture and evaluation of yellow fever vaccines, Geneva, Switzerland, 13\u201314 May 2009. Vaccine 28, 8236\u20138245 (2010).","journal-title":"Vaccine"},{"key":"3035_CR14","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1080\/22221751.2019.1694394","volume":"8","author":"DB Kum","year":"2019","unstructured":"Kum, D. B. et al. Limited evolution of the yellow fever virus 17d in a mouse infection model. Emerg. Microbes Infect. 8, 1734\u20131746 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"3035_CR15","doi-asserted-by":"crossref","first-page":"e02494","DOI":"10.1128\/mBio.02494-19","volume":"11","author":"N Mishra","year":"2020","unstructured":"Mishra, N. et al. A chimeric Japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies. MBio 11, e02494-19 (2020).","journal-title":"MBio"},{"key":"3035_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","volume":"86","author":"RE Thomas","year":"2012","unstructured":"Thomas, R. E., Lorenzetti, D. L., Spragins, W., Jackson, D. & Williamson, T. The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review. Am. J. Trop. Med. Hyg. 86, 359\u2013372 (2012).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"3035_CR17","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1016\/j.vaccine.2013.09.030","volume":"31","author":"E Rafferty","year":"2013","unstructured":"Rafferty, E., Duclos, P., Yactayo, S. & Schuster, M. Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review. Vaccine 31, 5798\u20135805 (2013).","journal-title":"Vaccine"},{"key":"3035_CR18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4269\/ajtmh.2007.77.919","volume":"77","author":"RI Mateo","year":"2007","unstructured":"Mateo, R. I. et al. Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters. Am. J. Trop. Med. Hyg. 77, 919\u2013924 (2007).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"3035_CR19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1099\/vir.0.000075","volume":"96","author":"AK Erickson","year":"2015","unstructured":"Erickson, A. K. & Pfeiffer, J. K. Spectrum of disease outcomes in mice infected with YFV-17D. J. Gen. Virol. 96, 1328\u20131339 (2015).","journal-title":"J. Gen. Virol."},{"key":"3035_CR20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005786","volume":"12","author":"AM Watson","year":"2016","unstructured":"Watson, A. M., Lam, L. K., Klimstra, W. B. & Ryman, K. D. The 17D\u2013204 vaccine strain-induced protection against virulent yellow fever virus is mediated by humoral immunity and CD4+ but not CD8+ T cells. PLoS Pathog. 12, e1005786 (2016).","journal-title":"PLoS Pathog."},{"key":"3035_CR21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/hv.22982","volume":"9","author":"RM Martins","year":"2013","unstructured":"Martins, R. M. et al. 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Hum. Vaccin. Immunother. 9, 879\u2013888 (2013).","journal-title":"Hum. Vaccin. Immunother."},{"key":"3035_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid0803.010238","volume":"8","author":"RB Tesh","year":"2002","unstructured":"Tesh, R. B., Travassos da Rosa, A. P., Guzman, H., Araujo, T. P. & Xiao, S. Y. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg. Infect. Dis. 8, 245\u2013251 (2002).","journal-title":"Emerg. Infect. Dis."},{"key":"3035_CR23","first-page":"2428","volume":"71","author":"JF-W Chan","year":"2020","unstructured":"Chan, J. F.-W. et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. 71, 2428\u20132446 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"3035_CR24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","volume":"583","author":"SF Sia","year":"2020","unstructured":"Sia, S. F. et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834\u2013838 (2020).","journal-title":"Nature"},{"key":"3035_CR25","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1073\/pnas.2018975117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl Acad. Sci. USA 117, 16587\u201316595 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3035_CR26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.abb7314","volume":"368","author":"B Rockx","year":"2020","unstructured":"Rockx, B. et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 368, 1012\u20131015 (2020).","journal-title":"Science"},{"key":"3035_CR27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","volume":"586","author":"N van Doremalen","year":"2020","unstructured":"van Doremalen, N. et al. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature 586, 578\u2013582 (2020).","journal-title":"Nature"},{"key":"3035_CR28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","volume":"369","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science 369, 806\u2013811 (2020).","journal-title":"Science"},{"key":"3035_CR29","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0205-6","volume":"5","author":"JE Staples","year":"2020","unstructured":"Staples, J. E., Barrett, A. D. T., Wilder-Smith, A. & Hombach, J. Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection. npj Vaccines 5, 54 (2020).","journal-title":"npj Vaccines"},{"key":"3035_CR30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJMoa1710430","volume":"381","author":"RM Casey","year":"2019","unstructured":"Casey, R. M. et al. Immunogenicity of fractional-dose vaccine during a yellow fever outbreak - final report. N. Engl. J. Med. 381, 444\u2013454 (2019).","journal-title":"N. Engl. J. Med."},{"key":"3035_CR31","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","volume":"182","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell 182, 828\u2013842.e16 (2020).","journal-title":"Cell"},{"key":"3035_CR32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000614","volume":"5","author":"KC Meier","year":"2009","unstructured":"Meier, K. C., Gardner, C. L., Khoretonenko, M. V., Klimstra, W. B. & Ryman, K. D. A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog. 5, e1000614 (2009).","journal-title":"PLoS Pathog."},{"key":"3035_CR33","doi-asserted-by":"crossref","first-page":"12392","DOI":"10.1128\/JVI.02149-13","volume":"87","author":"AK Erickson","year":"2013","unstructured":"Erickson, A. K. & Pfeiffer, J. K. Dynamic viral dissemination in mice infected with yellow fever virus strain 17D. J. Virol. 87, 12392\u201312397 (2013).","journal-title":"J. Virol."},{"key":"3035_CR34","volume":"3","author":"DB Kum","year":"2018","unstructured":"Kum, D. B. et al. A yellow fever\u2013Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice. npj Vaccines 3, 56 (2018).","journal-title":"npj Vaccines"},{"key":"3035_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19, 181\u2013193 (2016).","journal-title":"Cell Host Microbe"},{"key":"3035_CR36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar, R. & Perlman, S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 39, 529\u2013539 (2017).","journal-title":"Semin. Immunopathol."},{"key":"3035_CR37","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1128\/JVI.01689-12","volume":"86","author":"C Page","year":"2012","unstructured":"Page, C. et al. Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection. J. Virol. 86, 13334\u201313349 (2012).","journal-title":"J. Virol."},{"key":"3035_CR38","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e15 (2020).","journal-title":"Cell"},{"key":"3035_CR39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","volume":"52","author":"L Ni","year":"2020","unstructured":"Ni, L. et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 52, 971\u2013977.e3 (2020).","journal-title":"Immunity"},{"key":"3035_CR40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","volume":"9","author":"MB Appaiahgari","year":"2010","unstructured":"Appaiahgari, M. B. & Vrati, S. IMOJEV\u00ae: a yellow fever virus-based novel Japanese encephalitis vaccine. Expert Rev. Vaccines 9, 1371\u20131384 (2010).","journal-title":"Expert Rev. Vaccines"},{"key":"3035_CR41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/14760584.2017.1335201","volume":"16","author":"B Guy","year":"2017","unstructured":"Guy, B. et al. A recombinant live attenuated tetravalent vaccine for the prevention of dengue. Expert Rev. Vaccines 16, 671\u2013684 (2017).","journal-title":"Expert Rev. Vaccines"},{"key":"3035_CR42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","volume":"369","author":"Q Gao","year":"2020","unstructured":"Gao, Q. et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 369, 77\u201381 (2020).","journal-title":"Science"},{"key":"3035_CR43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","volume":"182","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell 182, 713\u2013721.e9 (2020).","journal-title":"Cell"},{"key":"3035_CR44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","volume":"586","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586, 572\u2013577 (2020).","journal-title":"Nature"},{"key":"3035_CR45","volume":"11","author":"L Feng","year":"2020","unstructured":"Feng, L. et al. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Nat. Commun. 11, 4207 (2020).","journal-title":"Nat. Commun."},{"key":"3035_CR46","doi-asserted-by":"crossref","first-page":"eabc9396","DOI":"10.1126\/scitranslmed.abc9396","volume":"12","author":"JH Erasmus","year":"2020","unstructured":"Erasmus, J. H. et al. An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Sci. Transl. Med. 12, eabc9396 (2020).","journal-title":"Sci. Transl. Med."},{"key":"3035_CR47","unstructured":"WHO. International Travel and Health. Yellow fever, https:\/\/www.who.int\/ith\/vaccines\/yf\/en\/ (accessed 4 November 2020)."},{"key":"3035_CR48","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1016\/j.vaccine.2020.05.064","volume":"38","author":"PH Lambert","year":"2020","unstructured":"Lambert, P. H. et al. Consensus summary report for CEPI\/BC March 12-13, 2020 meeting: assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine 38, 4783\u20134791 (2020).","journal-title":"Vaccine"},{"key":"3035_CR49","volume":"4","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019).","journal-title":"JCI Insight"},{"key":"3035_CR50","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3389\/fmicb.2018.02991","volume":"9","author":"MK Smatti","year":"2018","unstructured":"Smatti, M. K., Al Thani, A. A. & Yassine, H. M. Viral-induced enhanced disease illness. Front. Microbiol. 9, 2991 (2018).","journal-title":"Front. Microbiol."},{"key":"3035_CR51","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1128\/JVI.71.12.9608-9617.1997","volume":"71","author":"BD Lindenbach","year":"1997","unstructured":"Lindenbach, B. D. & Rice, C. M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71, 9608\u20139617 (1997).","journal-title":"J. Virol."},{"key":"3035_CR52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","volume":"73","author":"UJ Buchholz","year":"1999","unstructured":"Buchholz, U. J., Finke, S. & Conzelmann, K. K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73, 251\u2013259 (1999).","journal-title":"J. Virol."},{"key":"3035_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2012.10.031","volume":"434","author":"K Dallmeier","year":"2013","unstructured":"Dallmeier, K. & Neyts, J. Simple and inexpensive three-step rapid amplification of cDNA 5\u2032 ends using 5\u2032 phosphorylated primers. Anal. Biochem. 434, 1\u20133 (2013).","journal-title":"Anal. Biochem."},{"key":"3035_CR54","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1080\/21645515.2020.1765621","volume":"16","author":"S Sharma","year":"2020","unstructured":"Sharma, S. et al. Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine. Hum. Vaccin. Immunother. 16, 2196\u20132203 (2020).","journal-title":"Hum. Vaccin. Immunother."},{"key":"3035_CR55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","volume":"345","author":"PJ Bredenbeek","year":"2006","unstructured":"Bredenbeek, P. J. et al. A recombinant yellow fever 17D vaccine expressing Lassa virus glycoproteins. Virology 345, 299\u2013304 (2006).","journal-title":"Virology"},{"key":"3035_CR56","doi-asserted-by":"crossref","DOI":"10.1038\/srep16532","volume":"5","author":"N Concei\u00e7\u00e3o-Neto","year":"2015","unstructured":"Concei\u00e7\u00e3o-Neto, N. et al. Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis. Sci. Rep. 5, 16532 (2015).","journal-title":"Sci. Rep."},{"key":"3035_CR57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-8682-8_7","volume":"1838","author":"N Concei\u00e7\u00e3o-Neto","year":"2018","unstructured":"Concei\u00e7\u00e3o-Neto, N., Yinda, K. C., Van Ranst, M. & Matthijnssens, J. NetoVIR: modular approach to customize sample preparation procedures for viral metagenomics. Methods Mol. Biol. 1838, 85\u201395 (2018).","journal-title":"Methods Mol. Biol."},{"key":"3035_CR58","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U M\u00fcller","year":"1994","unstructured":"M\u00fcller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918\u20131921 (1994).","journal-title":"Science"},{"key":"3035_CR59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00090.x","volume":"148","author":"MF van den Broek","year":"1995","unstructured":"van den Broek, M. F., M\u00fcller, U., Huang, S., Zinkernagel, R. M. & Aguet, M. Immune defence in mice lacking type I and\/or type II interferon receptors. Immunol. Rev. 148, 5\u201318 (1995).","journal-title":"Immunol. Rev."},{"key":"3035_CR60","volume":"9","author":"Z Fan","year":"2014","unstructured":"Fan, Z. et al. Efficient gene targeting in golden Syrian hamsters by the CRISPR\/Cas9 system. PLoS ONE 9, e109755 (2014).","journal-title":"PLoS ONE"},{"key":"3035_CR61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virol.2017.04.013","volume":"507","author":"V Siddharthan","year":"2017","unstructured":"Siddharthan, V. et al. Zika virus infection of adult and fetal STAT2 knock-out hamsters. Virology 507, 89\u201395 (2017).","journal-title":"Virology"},{"key":"3035_CR62","first-page":"2000045","volume":"25","author":"VM Corman","year":"2020","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25, 2000045 (2020).","journal-title":"Euro Surveill."},{"key":"3035_CR63","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct\u00a0method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"3035_CR64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"3035_CR65","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1109\/TNS.2013.2275994","volume":"60","author":"B Vandeghinste","year":"2012","unstructured":"Vandeghinste, B. et al. Iterative CT reconstruction using shearlet-based regularization. IEEE Trans. Nucl. Sci. 60, 3305\u20133317 (2012).","journal-title":"IEEE Trans. Nucl. Sci."},{"key":"3035_CR66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1242\/dmm.020321","volume":"9","author":"G Vande Velde","year":"2016","unstructured":"Vande Velde, G. et al. Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume. Dis. Model. Mech. 9, 91\u201398 (2016).","journal-title":"Dis. Model. Mech."},{"key":"3035_CR67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53876-x","volume":"9","author":"N Berghen","year":"2019","unstructured":"Berghen, N. et al. Radiosafe micro-computed tomography for longitudinal evaluation of murine disease models. Sci. Rep. 9, 17598 (2019).","journal-title":"Sci. Rep."},{"key":"3035_CR68","doi-asserted-by":"publisher","unstructured":"Kaptein, S. J. et al. Antiviral treatment of SARS-CoV-2-infected hamsters reveals a weak effect of favipiravir and a complete lack of effect for hydroxychloroquine. Preprint at https:\/\/doi.org\/10.1101\/2020.06.19.159053 (2020).","DOI":"10.1101\/2020.06.19.159053"},{"key":"3035_CR69","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1542","volume":"44","author":"JM Geisinger","year":"2016","unstructured":"Geisinger, J. M., Turan, S., Hernandez, S., Spector, L. P. & Calos, M. P. In vivo blunt-end cloning through CRISPR\/Cas9-facilitated non-homologous end-joining. Nucleic Acids Res. 44, e76 (2016).","journal-title":"Nucleic Acids Res."},{"key":"3035_CR70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","volume":"169","author":"MA Whitt","year":"2010","unstructured":"Whitt, M. A. Generation of VSV pseudotypes using recombinant \u0394G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J. Virol. Methods 169, 365\u2013374 (2010).","journal-title":"J. Virol. Methods"},{"key":"3035_CR71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025858","volume":"6","author":"M Berger Rentsch","year":"2011","unstructured":"Berger Rentsch, M. & Zimmer, G. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS ONE 6, e25858 (2011).","journal-title":"PLoS ONE"},{"key":"3035_CR72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"3035_CR73","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1099\/vir.0.80955-0","volume":"86","author":"S Fukushi","year":"2005","unstructured":"Fukushi, S. et al. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J. Gen. Virol. 86, 2269\u20132274 (2005).","journal-title":"J. Gen. Virol."},{"key":"3035_CR74","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat. Commun. 11, 2511 (2020).","journal-title":"Nat. Commun."},{"key":"3035_CR75","doi-asserted-by":"crossref","first-page":"e01381","DOI":"10.1128\/JVI.01381-18","volume":"93","author":"H Kleine-Weber","year":"2019","unstructured":"Kleine-Weber, H. et al. Mutations in the spike protein of Middle East respiratory syndrome coronavirus transmitted in Korea increase resistance to antibody-mediated neutralization. J. Virol. 93, e01381-18 (2019).","journal-title":"J. Virol."},{"key":"3035_CR76","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1128\/JVI.78.22.12591-12602.2004","volume":"78","author":"A Op De Beeck","year":"2004","unstructured":"Op De Beeck, A., Rouill\u00e9, Y., Caron, M., Duvet, S. & Dubuisson, J. The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals. J. Virol. 78, 12591\u201312602 (2004).","journal-title":"J. Virol."},{"key":"3035_CR77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","volume":"4","author":"MC Bonaldo","year":"2007","unstructured":"Bonaldo, M. C. et al. Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol. J. 4, 115 (2007).","journal-title":"Virol. J."},{"key":"3035_CR78","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","volume":"25","author":"V Barban","year":"2007","unstructured":"Barban, V. et al. High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production. Vaccine 25, 2941\u20132950 (2007).","journal-title":"Vaccine"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-3035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-3035-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-3035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:08:39Z","timestamp":1684606119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-3035-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":78,"journal-issue":{"issue":"7845","published-print":{"date-parts":[[2021,2,11]]}},"alternative-id":["3035"],"URL":"https:\/\/doi.org\/10.1038\/s41586-020-3035-9","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.S.-F., J.N. and K.D. are named as inventors on a patent describing the invention and use of coronavirus vaccines. All other authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}